Vision Outcomes in Children Treated With Voretigene Neparvovec for RPE65-Associated Retinopathy.
- DOI
- 10.1001/jamaophthalmol.2025.5505
- Published
- 2026 Feb 1
- Container
- JAMA ophthalmology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1001/jamaophthalmol.2025.5505,
title = {Vision Outcomes in Children Treated With Voretigene Neparvovec for RPE65-Associated Retinopathy.},
author = {Thompson DA and De Smit E and Tan W and Handley SE and Marmoy OR and Henderson RH},
year = {2026},
journal = {JAMA ophthalmology},
doi = {10.1001/jamaophthalmol.2025.5505},
url = {https://doi.org/10.1001/jamaophthalmol.2025.5505}
}RIS
TY - JOUR TI - Vision Outcomes in Children Treated With Voretigene Neparvovec for RPE65-Associated Retinopathy. AU - Thompson DA AU - De Smit E AU - Tan W AU - Handley SE AU - Marmoy OR AU - Henderson RH PY - 2026 JO - JAMA ophthalmology DO - 10.1001/jamaophthalmol.2025.5505 UR - https://doi.org/10.1001/jamaophthalmol.2025.5505 ER -
APA
DA, T., E, D. S., W, T., SE, H., OR, M., & RH, H. (2026). Vision Outcomes in Children Treated With Voretigene Neparvovec for RPE65-Associated Retinopathy.. JAMA ophthalmology. https://doi.org/10.1001/jamaophthalmol.2025.5505
Source records
- pubmed · retrieved 2026-09-27T13:12:14.177Z
- europe-pmc · retrieved 2026-09-27T13:12:14.193Z